177 related articles for article (PubMed ID: 23628063)
21. Epstein-Barr virus-associated T-cell lymphoproliferative disorder affecting skin and lung in an elderly patient.
Hoshino T; Tatsuno K; Shimauchi T; Okada S; Ito T; Ono T; Ohshima K; Tokura Y
J Dermatol; 2014 Sep; 41(9):837-40. PubMed ID: 25109697
[TBL] [Abstract][Full Text] [Related]
22. Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.
Chen G; Chen L; Qin X; Huang Z; Xie X; Li G; Xu B
Int J Clin Exp Pathol; 2014; 7(10):7110-3. PubMed ID: 25400806
[TBL] [Abstract][Full Text] [Related]
23. [Clinical features and laboratory findings of adult Epstein-Barr virus associated T/NK lymphoproliferative disease].
Zhang Q; Zhang HY; Zhang WL; Zhong FL; Feng J; Meng QX; Yin WH; Nie LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):953-7. PubMed ID: 23998592
[TBL] [Abstract][Full Text] [Related]
24. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Disorders Manifested as Gastrointestinal Perforations and Skin Lesions: A Case Report.
Xiao HJ; Li J; Song HM; Li ZH; Dong M; Zhou XG
Medicine (Baltimore); 2016 Feb; 95(5):e2676. PubMed ID: 26844502
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease.
Kawa K
Int J Hematol; 2003 Jul; 78(1):24-31. PubMed ID: 12894847
[TBL] [Abstract][Full Text] [Related]
27. Primary Intestinal Epstein-Barr Virus-associated Natural Killer/T-cell Lymphoproliferative Disorder: A Disease Mimicking Inflammatory Bowel Disease.
Wang Z; Zhang W; Luo C; Zhu M; Zhen Y; Mu J; Zhang Y; Hu R; Wang Y; Wen Z; Ouyang Q; Xiao S; Zhang H
J Crohns Colitis; 2018 Jul; 12(8):896-904. PubMed ID: 29635312
[TBL] [Abstract][Full Text] [Related]
28. Central nervous system vasculitis from Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children: A case report.
Lee MS; Hwang SK; Kim YE; Suh JK; Kim H; Lee SM; Jeong JY; Kwon S; Lee YJ
Brain Dev; 2019 Oct; 41(9):820-825. PubMed ID: 31208818
[TBL] [Abstract][Full Text] [Related]
29. Differential chemokine, chemokine receptor and cytokine expression in Epstein-Barr virus-associated lymphoproliferative diseases.
Ohshima K; Karube K; Hamasaki M; Tutiya T; Yamaguchi T; Suefuji H; Suzuki K; Suzumiya J; Ohga S; Kikuchi M
Leuk Lymphoma; 2003 Aug; 44(8):1367-78. PubMed ID: 12952231
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection.
Zhang Y; Ohyashiki JH; Takaku T; Shimizu N; Ohyashiki K
Br J Cancer; 2006 Feb; 94(4):599-608. PubMed ID: 16449999
[TBL] [Abstract][Full Text] [Related]
32. T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice.
Coles RE; Boyle TJ; DiMaio JM; Berend KR; Via DF; Lyerly HK
Ann Surg Oncol; 1994 Sep; 1(5):405-10. PubMed ID: 7531601
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of the Detection for the LPD Patients with EB Infection].
Su J; Wang SY; Liu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):702-5. PubMed ID: 26117021
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.
Cohen JI; Kimura H; Nakamura S; Ko YH; Jaffe ES
Ann Oncol; 2009 Sep; 20(9):1472-1482. PubMed ID: 19515747
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr Virus-positive T-cell Lymphoproliferative Disease Following Umbilical Cord Blood Transplantation for Acute Myeloid Leukemia.
Yui S; Yamaguchi H; Imadome K; Arai A; Takahashi M; Ohashi R; Tamai H; Moriya K; Nakayama K; Shimizu A; Inokuchi K
J Nippon Med Sch; 2016; 83(1):35-42. PubMed ID: 26960588
[TBL] [Abstract][Full Text] [Related]
36. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
37. Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease.
Shimoyama Y; Yamamoto K; Asano N; Oyama T; Kinoshita T; Nakamura S
Cancer Sci; 2008 Jun; 99(6):1085-91. PubMed ID: 18429953
[TBL] [Abstract][Full Text] [Related]
38. Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes.
Baiocchi RA; Caligiuri MA
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5577-81. PubMed ID: 7911241
[TBL] [Abstract][Full Text] [Related]
39. A look into the evolution of Epstein-Barr virus-induced lymphoproliferative disorders: a case study.
Ambrosio MR; Rocca BJ; Ginori A; Mourmouras V; Amato T; Vindigni C; Lazzi S; Leoncini L
Am J Clin Pathol; 2015 Nov; 144(5):817-22. PubMed ID: 26486748
[TBL] [Abstract][Full Text] [Related]
40. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
